LIDE
LIDE is an award-winning oncology contract research organization with 14 years of delivering drug evaluation services. We offer traditional preclinical CRO services like pharmacology, PK, and biomarker studies with 100+ CDX models and 2200 patient-derived xenograft (PDX) models. Our platform includes syngeneic, humanized and patient-derived samples for evaluation of T Cell engagers and bispecific antibodies. Ask us about our proprietary tools for in-vivo drug validation in 7-14 days.
